Career Center

Submit-a-Job_v2

Pros and Cons: Working in Small Life Sciences Companies vs. Large Organizations

Is your dream job with a large organization or a small company? It’s common for life sciences professionals to have a preference one way or the other when considering employment opportunities. While many people might have a primary reason for desiring to work at a small company or a large organization, most individuals haven’t really compared the differences and the implications on their career. Are you impressed by large established organizations? Or, do you seek out innovative start-ups and small companies? To help with your career planning, we’ve compiled a list of the major pros and cons when working in small companies versus large organizations!

Learn More

Cell Density and Viability Comparability Studies

Cell density and viability are critical process parameters in many cell culture applications for biologics development and production. Monitoring the health and growth of the culture is so important that numerous methods have been developed to meet this need. Automated cell counting has become the gold standard in many applications due to its consistency, accuracy, and ease of use. Additionally, by trypan blue dye exclusion method some systems integrate directly with bioreactors or microbioreactor systems to provide on-line measurement, streamlining workflow. Learn More

Wacker to Upgrade Production of Biologics and Vaccines at Amsterdam Site

Wacker is investing in its production facilities for biologics, LMPs (live microbial products) and vaccines at its Amsterdam site. Projects include the construction of a new fermentation line with a volume of 1,500 liters as well as the setting up of new cleanroom structures in the 270-liter fermentation line. According to the company, the investment price is a mid-double-digit million-euro amount. Among other improvements, new utility supplies are planned, such as water for injection. These measures will contribute to preparing the plant to produce new classes of actives, such as pDNA and mRNA-based vaccines. Learn More